Date published: 2025-10-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

VAP-1 Inhibitors

Vascular adhesion protein-1 (VAP-1), also known as amine oxidase copper-containing 3 (AOC3), is a cell surface glycoprotein primarily expressed in endothelial cells of post-capillary venules in various tissues. It plays a crucial role in leukocyte trafficking and inflammation by mediating the adhesion and transmigration of leukocytes from the bloodstream into inflamed tissues. VAP-1 functions as a dual-function enzyme, possessing both adhesive and enzymatic activities. Its adhesive function involves interactions with leukocyte integrins and other cell adhesion molecules, facilitating the tethering and rolling of leukocytes along the endothelial surface. Additionally, VAP-1 exhibits amine oxidase activity, catalyzing the oxidative deamination of primary amines, which generates hydrogen peroxide and aldehyde by-products. These enzymatic activities contribute to the regulation of leukocyte migration and inflammation by modulating the redox environment and generating chemotactic signals for immune cells. Inhibition of VAP-1 represents a promising strategy for mitigating inflammatory responses and suppressing leukocyte recruitment in various inflammatory disorders. Several mechanisms can be employed to inhibit VAP-1 activity, including blocking its enzymatic activity or interfering with its adhesive interactions with leukocyte receptors and endothelial ligands. Enzymatic inhibition of VAP-1 can be achieved by targeting its active site or disrupting its cofactor binding sites, thereby disrupting the oxidation of primary amines and the generation of pro-inflammatory mediators. Alternatively, inhibition of VAP-1-mediated leukocyte adhesion can be accomplished by blocking its interaction with endothelial ligands or leukocyte integrins through competitive antagonism or steric hindrance. Additionally, modulation of VAP-1 expression and trafficking to the cell surface can also serve as effective strategies for inhibiting its pro-inflammatory functions. Overall, inhibition of VAP-1 holds significant importance for attenuating inflammation and curbing tissue damage in various inflammatory conditions.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Mofegiline hydrochloride

120635-25-8sc-269606
sc-269606A
250 mg
1 g
$1300.00
$2889.00
(0)

Mofegiline hydrochloride acts as a VAP-1 inhibitor, engaging in specific molecular interactions that disrupt the enzyme's function. Its unique binding affinity alters the enzyme's active site conformation, impacting substrate recognition and catalytic efficiency. The compound exhibits distinct reaction kinetics, characterized by a rapid onset of inhibition, which facilitates the exploration of cellular adhesion pathways. This specificity provides insights into the regulation of inflammatory responses at the molecular level.